Concurrent Testing for COVID-19 and HIV Infection at 6 High-Volume Emergency Departments in a Priority Jurisdiction for Ending the HIV Epidemic in the United States.
Concurrent Testing for COVID-19 and HIV Infection at 6 High-Volume Emergency Departments in a Priority Jurisdiction for Ending the HIV Epidemic in the United States.
复制标题
DOI：
10.1097/qai.0000000000003287
复制
发表时间：
2023-12-01
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
新冠肺炎大流行导致人们无法进行常规的艾滋病毒筛查。我们评估了伊利诺伊州库克县6个急诊科的艾滋病毒和严重急性呼吸综合征冠状病毒2(SARS-CoV-2)检测。我们回顾分析了SARS-CoV-2检测的次数、HIV筛查以及同时检测(同时遇到SARS-CoV-2和HIV检测)与新的和急性HIV感染的诊断相关的比例。5个站点报告了2020年3月1日至2021年2月28日的数据，1个站点报告了2020年9月1日至2021年2月28日的数据。总共进行了1，13,645次SARS-CoV-2和36,094次艾滋病毒检测；其中17,469次是同时检测。新增艾滋病毒诊断病例102例，包括25例急性感染病例。不同地点的并发测试比例从6.7%到37%不等(P<；0.001)。HIV检测量与新诊断数呈正相关(r=0.66，P<；0.01)。有症状的SARS-CoV-2检测与急性感染的诊断密切相关(r=0.87，P<；0.001)；当控制HIV检测量时，这种相关性没有统计学意义(r=0.59，P=0.056)。急性患者更有可能接受同时检测(21/25)，而不是其他新诊断(29/77；优势比=8.69，95%CI：2.7至27.8，P<；0.001)。把艾滋病毒筛查纳入教育署的SARS-CoV-2检测中，有助于保持艾滋病毒筛查量。尽管所有到急诊室就诊的病人都应该接受选择退出的艾滋病毒筛查，但对有新冠肺炎症状或其他病毒疾病的患者进行检测，可以提供机会诊断出有症状的急性和早期艾滋病毒感染，迅速与护理联系起来，并开始治疗。
The COVID-19 pandemic caused disruptions in access to routine HIV screening. We assess HIV and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing across 6 emergency departments (EDs) in Cook County, Illinois. We retrospectively analyzed the number of SARS-CoV-2 tests, HIV screens, and the proportion of concurrent tests (encounters with both SARS-CoV-2 and HIV testing), correlating with diagnoses of new and acute HIV infection. Five sites reported data from March 1, 2020, to February 28, 2021, and 1 site from September 1, 2020, to February 28, 2021. A total of 1,13,645 SARS-CoV-2 and 36,094 HIV tests were performed; 17,469 of these were concurrent tests. There were 102 new HIV diagnoses, including 25 acute infections. Concurrent testing proportions ranged from 6.7% to 37% across sites (P < 0.001). HIV testing volume correlated with the number of new diagnoses (r = 0.66, P < 0.01). HIV testing with symptomatic SARS-CoV-2 testing was strongly correlated with diagnosis of acute infections (r = 0.87, P < 0.001); this was not statistically significant when controlling for HIV testing volumes (r = 0.59, P = 0.056). Acute patients were more likely to undergo concurrent testing (21/25) versus other new diagnoses (29/77; odds ratio = 8.69, 95% CI: 2.7 to 27.8, P < 0.001). Incorporating HIV screening into SARS-CoV-2 testing in the ED can help maintain HIV screening volumes. Although all patients presenting to the ED should be offered opt-out HIV screening, testing individuals with symptoms of COVID-19 or other viral illness affords the opportunity to diagnose symptomatic acute and early HIV infection, rapidly link to care, and initiate treatment.
DOI：
10.3390/ijerph182010814
发表时间：
2021-10-14
影响因子：
--
作者：
Chow EPF;Ong JJ;Donovan B;Foster R;Phillips TR;McNulty A;Fairley CK
通讯作者：
Fairley CK